Srinivas Muvvala, MD, MPH
Associate Professor of PsychiatryCards
About
Research
Publications
2026
Contingency Management for Stimulant-Opioid Co-Use: A Systematic Review and Meta-Analysis.
Jegede O, Oliva H, Prudente T, Rash C, Muvvala S, Angarita G. Contingency Management for Stimulant-Opioid Co-Use: A Systematic Review and Meta-Analysis. Journal Of Addiction Medicine 2026 PMID: 42109226, DOI: 10.1097/adm.0000000000001708.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsUrgent response is needed to address the stimulant-fentanyl related overdose crisis
Mills R, Jegede O, Muvvala S. Urgent response is needed to address the stimulant-fentanyl related overdose crisis. Frontiers In Psychiatry 2026, 17: 1769408. PMID: 41924706, PMCID: PMC13035785, DOI: 10.3389/fpsyt.2026.1769408.Peer-Reviewed Original Research
2025
Collaborating Across the Globe: The Yale-University of Jordan International Interprofessional Addiction Education Program
Muvvala S, Minahan-Rowley R, Al-Khateeb Y, Abu-Dahab R, Khoshnood K, Wazaify M, Tetrault J. Collaborating Across the Globe: The Yale-University of Jordan International Interprofessional Addiction Education Program. Substance Use & Addiction Journal 2025, 46: 1013-1018. PMID: 40913374, DOI: 10.1177/29767342251331389.Peer-Reviewed Original ResearchPrenatal opioid exposure alters pain perception and increases long-term health risks in infants with neonatal opioid withdrawal syndrome
Radhakrishna U, Radhakrishnan R, Uppala L, Trivedi T, Prajapati J, Rawal R, Muvvala S, Bahado-Singh R, Sadhasivam S. Prenatal opioid exposure alters pain perception and increases long-term health risks in infants with neonatal opioid withdrawal syndrome. Frontiers In Pain Research 2025, 6: 1497801. PMID: 40313396, PMCID: PMC12043715, DOI: 10.3389/fpain.2025.1497801.Peer-Reviewed Original ResearchNovel Elective Course on Substance Use for Pharmacy Students in Jordan
Wazaify M, Al-Khateeb Y, Khoshnood K, Muvvala S, Minahan-Rowley R, Abu-Dahab R, Tetrault J. Novel Elective Course on Substance Use for Pharmacy Students in Jordan. American Journal Of Pharmaceutical Education 2025, 89: 101399. PMID: 40158728, DOI: 10.1016/j.ajpe.2025.101399.Peer-Reviewed Original ResearchE-Cigarette Use in Teens: Recent Trends and Future Implications
Potluri H, Muvvala S. E-Cigarette Use in Teens: Recent Trends and Future Implications. Journal Of Student Research 2025, 14 DOI: 10.47611/jsrhs.v14i1.8471.Peer-Reviewed Original ResearchPreliminary effects of oral ANS-6637, an ALDH2 inhibitor, on cue-induced craving, safety and alcohol consumption among adults with alcohol use disorder: a proof-of-concept, randomized, human laboratory trial
O’Malley S, Miranda R, Book S, Chun T, Liss T, Malcolm R, Muvvala S, Padovano H, Schacht J, Blackburn B, Diamond I, Ransom J, Ryan M, Falk D, Litten R. Preliminary effects of oral ANS-6637, an ALDH2 inhibitor, on cue-induced craving, safety and alcohol consumption among adults with alcohol use disorder: a proof-of-concept, randomized, human laboratory trial. Alcohol And Alcoholism 2025, 60: agaf001. PMID: 39829301, PMCID: PMC11744046, DOI: 10.1093/alcalc/agaf001.Peer-Reviewed Original Research
2024
Availability of Medications for Opioid Use Disorder in US Psychiatric Hospitals
Cohen S, Beetham T, Fiellin D, Muvvala S. Availability of Medications for Opioid Use Disorder in US Psychiatric Hospitals. JAMA Network Open 2024, 7: e2444679. PMID: 39535800, PMCID: PMC11561693, DOI: 10.1001/jamanetworkopen.2024.44679.Peer-Reviewed Original ResearchPrenatal opioid exposure significantly impacts placental protein kinase C (PKC) and drug transporters, leading to drug resistance and neonatal opioid withdrawal syndrome
Radhakrishna U, Radhakrishnan R, Uppala L, Muvvala S, Prajapati J, Rawal R, Bahado-Singh R, Sadhasivam S. Prenatal opioid exposure significantly impacts placental protein kinase C (PKC) and drug transporters, leading to drug resistance and neonatal opioid withdrawal syndrome. Frontiers In Neuroscience 2024, 18: 1442915. PMID: 39238930, PMCID: PMC11376091, DOI: 10.3389/fnins.2024.1442915.Peer-Reviewed Original ResearchThe Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review
Jegede O, De Aquino J, Hsaio C, Caldwell E, Funaro M, Petrakis I, Muvvala S. The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review. Journal Of Addiction Medicine 2024, 18: 499-510. PMID: 39356620, PMCID: PMC11449257, DOI: 10.1097/adm.0000000000001356.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
Academic Achievements & Community Involvement
News
News
- August 14, 2026
Muvvala to Receive 2026 Award for Residency Education from AAAP
- May 12, 2026Source: Journal of Addiction Medicine
Contingency Management for Stimulant-Opioid Co-Use: A Systematic Review and Meta-Analysis
- October 03, 2025
Opinion: Inpatient Psychiatry Treatment Programs Must Step Up to Integrate Opioid Use Disorder Treatment
- November 14, 2024
Why Do So Few U.S. Psych Hospitals Use Medications for Opioid Use Disorder?